Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-12-02 pm EST 		5-day change 1st Jan Change
799.80 USD +0.56% Intraday chart for Eli Lilly and Company +5.93% +37.21%
Dec. 02 Health Care Flat on Mixed Obesity-Drug Fortunes - Health Care Roundup DJ
Dec. 02 Tesla leads November's global market value surge RE

Chart calendar Eli Lilly and Company

c7da5.pKmMiVPesn7DdCx87EPjkzE-hsoEOZ5VvmEKdXHz5Is.1P69vgec9TaEHxkkhwHR23R_6bJKfNcfhwhcFD63q-3A-8rhC4r1FfIwdQ~42cd8c60da6b547da5baca7e121befc4

Upcoming events on Eli Lilly and Company

2024-12-08 09:00 pm American Society of Hematology Meeting - Abstract #2785
2024-12-09 06:30 pm American Society of Hematology Meeting - Abstract #886
2024-12-09 09:00 pm American Society of Hematology Meeting - Abstract #5114
2024-12-09 09:00 pm American Society of Hematology Meeting - Abstract #5033
2024-12-11 08:00 am San Antonio Breast Cancer Symposium - Presentation No.: PS7-03
2024-12-11 10:15 am San Antonio Breast Cancer Symposium - Presentation No.: GS1-01
2024-12-11 01:00 pm San Antonio Breast Cancer Symposium - Presentation No.: P1-11-29
2024-12-11 01:00 pm San Antonio Breast Cancer Symposium - Presentation No.: P1-01-26
2024-12-11 01:00 pm San Antonio Breast Cancer Symposium - Presentation No.: P1-11-02
2024-12-12 06:30 pm San Antonio Breast Cancer Symposium - Presentation No.: P4-12-24
2024-12-12 06:30 pm San Antonio Breast Cancer Symposium - Presentation No.: P4-10-07
2024-12-12 06:30 pm San Antonio Breast Cancer Symposium - Presentation No.: P4-03-11
2024-12-13 01:00 pm San Antonio Breast Cancer Symposium - Presentation No.: P5-02-23
2025-01-29 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

2024-11-14 Détachement de
2024-11-02 ObesityWeek Conference
2024-10-30 10:00 am Q3 2024 Earnings Call
2024-10-30 06:45 am Q3 2024 Earnings Release
2024-10-23 Fall Clinical Dermatology Conference
2024-10-11 United European Gastroenterology Week Meeting
2024-09-09 European Association for the Study of Diabetes Meeting
2024-09-05 07:45 am Morgan Stanley Healthcare Conference
2024-08-14 Détachement de
2024-08-08 10:00 am Q2 2024 Earnings Call
2024-08-08 06:45 am Q2 2024 Earnings Release
2024-06-21 03:45 pm American Diabetes Association Scientific Symposium
2024-06-10 04:00 pm Goldman Sachs Global Healthcare Conference - Fireside Chat
2024-06-03 06:12 pm American Society of Clinical Oncology Meeting - Abstract Number: LBA507
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 8547
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 5589
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 11111
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 11068
2024-06-02 08:30 pm American Society of Clinical Oncology Meeting
2024-06-02 06:06 pm American Society of Clinical Oncology Meeting - Abstract Number: 10022

Past dividends on Eli Lilly and Company

2024-11-14 Quarterly 1.3 USD
2024-08-14 Quarterly 1.3 USD
2024-05-14 Quarterly 1.3 USD
2024-02-13 Quarterly 1.3 USD
2023-11-13 Quarterly 1.13 USD
2023-08-13 Quarterly 1.13 USD
2023-05-11 Quarterly 1.13 USD
2023-02-13 Quarterly 1.13 USD
2022-11-13 Quarterly 0.98 USD
2022-08-11 Quarterly 0.98 USD
2022-05-12 Quarterly 0.98 USD
2022-02-13 Quarterly 0.98 USD
2021-11-11 Quarterly 0.85 USD
2021-08-11 Quarterly 0.85 USD
2021-05-12 Quarterly 0.85 USD
2021-02-10 Quarterly 0.85 USD
2020-11-11 Quarterly 0.74 USD
2020-08-12 Quarterly 0.74 USD
2020-05-13 Quarterly 0.74 USD
2020-02-12 Quarterly 0.74 USD

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD		Released
Forecast
Spread 		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
45 658


58 403


69 955

EBITDA
Million USD		Released
Forecast
Spread 		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
16 126


26 259


33 453

EBIT
Million USD		Released
Forecast
Spread 		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
14 602


23 971


30 562

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
14 302


21 929


26 914

Net income
Million USD		Released
Forecast
Spread 		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
11 307


19 632


24 933

EPS
USD		Released
Forecast
Spread 		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
12,8


21,7


27,6

Announcement Date03/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%		11 303
9 968
13.4%		11 439
12 119
-5.61%
14 005


13 466


14 047


14 573


15 320

EBITDA
Million USD		Released
Forecast
Spread 		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%		4 268
3 848
10.91%
2 501


7 307













EBIT
Million USD		Released
Forecast
Spread 		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%		3 854
3 028
27.27%		1 747
2 347
-25.55%
5 939


5 373


5 823


5 972




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%		3 517
3 065
14.75%		1 588



5 429













Net income
Million USD		Released
Forecast
Spread 		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%		2 967
2 415
22.87%		970
1 177
-17.58%
10 595













EPS
USD		Released
Forecast
Spread 		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%		3,28
2,72
20.64%		1,07
1,54
-30.7%
5,41













Announcement Date27/04/2308/08/2302/11/2306/02/2430/04/2408/08/2430/10/24-----

Upcoming sector events for Eli Lilly and Company

2024-12-10 11:45 am MEDINCELL S.A.: Q2 2025 Earnings Release
2025-01-08 HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2025 Earnings Release
2025-01-12 TILRAY BRANDS, INC.: Q2 2025 Earnings Release (Projected)
2025-01-20 AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21 AARTI DRUGS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21 ALEMBIC PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-22 GLENMARK LIFE SCIENCES LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-27 GRANULES INDIA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-27 JOHNSON & JOHNSON: Q4 2024 Earnings Release (Projected)
2025-01-28 MANKIND PHARMA LIMITED: Q3 2025 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

2024-11-28 DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release
2024-11-15 01:38 am BAVARIAN NORDIC A/S: Q3 2024 Earnings Release
2024-11-14 11:01 pm CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release
2024-11-14 09:03 am GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release
2024-11-14 07:00 am OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release
2024-11-14 02:49 am IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release
2024-11-14 01:30 am DERMAPHARM HOLDING SE: Q3 2024 Earnings Release
2024-11-14 01:30 am ALK-ABELLÓ A/S: Q3 2024 Earnings Release
2024-11-13 DONGKOOK PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release
2024-11-13 HANALL BIOPHARMA CO., LTD.: Q3 2024 Earnings Release

Quarterly revenue - Rate of surprise

quality-estimates-chart ELI-LILLY-AND-COMPANY

Net sales - Rate of surprise

quality-estimates-chart ELI-LILLY-AND-COMPANY

Annual profits - Rate of surprise

quality-estimates-chart ELI-LILLY-AND-COMPANY
  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Calendar Eli Lilly and Company
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW